Buyback Update: Windlas Biotech Limited – Record Date Announced

As per the recent notification issued by the BSE, Windlas Biotech Limited has announced a buyback of equity shares via the tender offer route and has fixed April 24, 2026 as the Record Date to determine shareholder eligibility.

What this means for you

If you are holding shares of Windlas Biotech Limited as on the record date, you will be eligible to participate in the buyback offer. This provides an opportunity to tender your shares to the company, subject to the final buyback terms, including price and entitlement ratio, which will be announced separately.

Key highlights:

• Company: Windlas Biotech Limited
• Corporate Action: Buyback (Tender Offer)
• Buyback Size: Yet to be Announced
• Shares to be Bought Back: Not Announced
• Buyback Price: Yet to be Announced
• Face Value: Yet to be Announced
• Record Date: April 24, 2026
• Ex-Entitlement Date: April 24, 2026
• BSE Code: 543329

Our view

Buybacks are generally considered a positive signal, reflecting management’s confidence in the company’s fundamentals. They may also offer investors an opportunity to realize value, depending on the buyback price and acceptance ratio.

Next steps

We recommend that you:

• Review your holdings in Windlas Biotech Limited ahead of the record date.
• Stay tuned for further details on the buyback price, size, and process.
• Reach out to your relationship manager for assistance in evaluating participation.